The Role of PARP-1 and PARP-2 Enzymes in Metabolic Regulation and Disease

Bai, Péter, Cantó, Carles·2012·Cell Metabolism

Cited by (314)

Items 101–200 of 314

  1. Human PARP1 substrates and regulators of its catalytic activity: An updated overview
    Tao Zhu, Juyan Zheng, Lingling Huang, Yanhong Wang, Di-Fei Yao, Haibin Dai · 2023 · Frontiers in Pharmacology
  2. Deletion of PARP-2 induces hepatic cholesterol accumulation and decrease in HDL levels
    Magdolna Szántó, Attila Brunyánszki, Judit Márton, György Vámosi, Lilla Nagy, Tamás Fodor, Borbála Kiss, László Virág, Pál Gergely, Péter Bai · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  3. Real‐Time Cellular Imaging of Protein Poly(ADP‐ribos)ylation
    Annette Buntz, Sarah Schlesiger, Eva Gwosch, Michael F. Schmalz, Sascha Beneke, Elisa Ferrando‐May, Andreas Marx, Andreas Zumbusch · 2016 · Angewandte Chemie International Edition
  4. NAD+ Precursors: A Questionable Redundancy
    Carles Cantó · 2022 · Metabolites
  5. Long‐Term Activation of Glucagon‐like peptide‐1 receptor by Dulaglutide Prevents Diabetic Heart Failure and Metabolic Remodeling in Type 2 Diabetes
    Saiyang Xie, Min Zhang, Wenke Shi, Yun Xing, Yan Qin Huang, Wenxi Fang, Shi‐qiang Liu, Mengya Chen, Tong Zhang, Si Chen et al. · 2022 · Journal of the American Heart Association
  6. Balancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations
    Angelique Cercillieux, Eleonora Ciarlo, Carles Cantó · 2022 · Cellular and Molecular Life Sciences
  7. A systems-approach to NAD+ restoration
    Nichola J. Conlon, Dianne Ford · 2022 · Biochemical Pharmacology
  8. Neuroprotective Effects of PARP Inhibitors in Drosophila Models of Alzheimer’s Disease
    Maggiore, Anna, Casale, Assunta Maria, Toscanelli, Walter, Cappucci, Ugo, Rotili, Dante, Grieco, Maddalena, Gagné, Jean-Philippe, Poirier, Guy G., d’Erme, Maria, Piacentini, Lucia · 2022 · Cells
  9. Antagonistic crosstalk between SIRT1, PARP-1, and -2 in the regulation of chronic inflammation associated with aging and metabolic diseases
    Hun‐Taeg Chung, Yeonsoo Joe · 2014 · Integrative Medicine Research
  10. Nicotinamide riboside supplementation dysregulates redox and energy metabolism in rats: Implications for exercise performance
    I. A. Kourtzidis, Christina F. Dolopikou, A. N. Tsiftsis, Nikos V. Margaritelis, Anastasios A. Theodorou, Ioannis A Zervos, Maria P. Tsantarliotou, Aristidis S. Veskoukis, Ioannis S. Vrabas, Vassilis Paschalis et al. · 2018 · Experimental Physiology
  11. Role of PGC-1α in the Mitochondrial NAD+ Pool in Metabolic Diseases
    Jin‐Ho Koh, Jong‐Yeon Kim · 2021 · International Journal of Molecular Sciences
  12. Nicotinamide pre-treatment ameliorates NAD(H) hyperoxidation and improves neuronal function after severe hypoxia
    Pavan K. Shetty, Francesca Galeffi, Dennis A. Turner · 2013 · Neurobiology of Disease
  13. Mitotic Bookmarking: Maintaining Post-Mitotic Reprogramming of Transcription Reactivation
    Niraj Lodhi, Yingbiao Ji, Alexei V. Tulin · 2016 · Current Molecular Biology Reports
  14. PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis
    Weronika Wasyluk, Agnieszka Zwolak · 2021 · Journal of Inflammation Research
  15. NAD(H) and NADP(H) in plants and mammals
    Danying Lu, Murray Grant, Boon Leong Lim · 2025 · Molecular Plant
  16. Poly(ADP-Ribose) Polymerase 1-Sirtuin 1 Functional Interplay Regulates LPS-Mediated High Mobility Group Box 1 Secretion
    Thomas D. Walko, Valentina Di Caro, Jon D. Piganelli, Timothy R. Billiar, Robert S. B. Clark, Rajesh K. Aneja · 2014 · Molecular Medicine
  17. Concepts and Molecular Aspects in the Polypharmacology of PARP‐1 Inhibitors
    Daniela Passeri, Emidio Camaioni, Paride Liscio, Paola Sabbatini, Martina Ferri, Andrea Carotti, Nicola Giacchè, Roberto Pellicciari, Antimo Gioiello, Antonio Macchiarulo · 2015 · ChemMedChem
  18. Delayed PARP-1 Inhibition Alleviates Post-stroke Inflammation in Male Versus Female Mice: Differences and Similarities
    Jian Chen, Xiaoxi Li, Siyi Xu, Meijuan Zhang, Zhengzheng Wu, Xi Zhang, Yun Xu, Yanting Chen · 2020 · Frontiers in Cellular Neuroscience
  19. Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression
    Zeren Sun, Lanjie Li, Bingxin Zhai, Mengxuan Hu, Lei Haley Huang, Shihui Huang, Ye Liu, Xiangying Kong, Jie Cheng Xu, Jie Bai et al. · 2024 · Journal of Medicinal Chemistry
  20. Boosting mitochondrial health to counteract neurodegeneration
    Johannes Burtscher, Mario Romani, Greta Bernardo, Traian Popa, Elena Ziviani, Friedhelm Christoph Hummel, Vincenzo Sorrentino, Grégoire Paul Millet · 2022 · Progress in Neurobiology
  21. Ferroptosis: mechanism, immunotherapy and role in ovarian cancer
    Ke Guo, Miao Lu, Jianlei Bi, Tianyu Yao, Jian Gao, Fang Ren, Liancheng Zhu · 2024 · Frontiers in Immunology
  22. Ferroptosis: iron release mechanisms in the bioenergetic process
    Jaewang Lee, Jong‐Lyel Roh · 2025 · Cancer and Metastasis Reviews
  23. Specific and shared biological functions of PARP2 – is PARP2 really a lil’ brother of PARP1?
    Magdolna Szántó, José Yélamos, Péter Bai · 2024 · Expert Reviews in Molecular Medicine
  24. Uncovering the Invisible: Mono-ADP-ribosylation Moved into the Spotlight
    Ann-Katrin Hopp, Michael O. Hottiger · 2021 · Cells
  25. NAD+ bioavailability mediates PARG inhibition-induced replication arrest, intra S-phase checkpoint and apoptosis in glioma stem cells
    Jianfeng Li, Kate M. Saville, Md Ibrahim, Xuemei Zeng, Steve McClellan, Anusha Angajala, Alison Beiser, Joel Andrews, Mai Sun, Christopher A. Koczor et al. · 2021 · NAR Cancer
  26. Analysis of Poly(ADP-Ribose) Polymerases in Arabidopsis Telomere Biology
    Kara A. Boltz, Madhu Jasti, Jennifer M. Townley, Dorothy E. Shippen · 2014 · PLoS ONE
  27. RETRACTED: microRNA‐383 suppresses the PI3K‐AKT‐MTOR signaling pathway to inhibit development of cervical cancer via down‐regulating PARP2
    Peng Teng, Yan Jiao, Min Hao, Xin Tang · 2017 · Journal of Cellular Biochemistry · Retracted
  28. Depot-specific regulation of NAD+/SIRTs metabolism identified in adipose tissue of mice in response to high-fat diet feeding or calorie restriction
    Xiaojing Wei, Ru Jia, Guan Wang, Shangyu Hong, Lin Song, Bo Sun, Ke Chen, Nan Wang, Qiqi Wang, Xiao Min Luo et al. · 2020 · The Journal of Nutritional Biochemistry
  29. NAD+ Metabolism and Diseases with Motor Dysfunction
    Samuel Lundt, Shinghua Ding · 2021 · Genes
  30. Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside review
    Jiaqi Xiong, Ranya Barayan, Alexander V. Louie, Benjamin H. Lok · 2022 · Seminars in Cancer Biology
  31. Targeting ADP-ribosylation as an antimicrobial strategy
    Giuliana Catara, Annunziata Corteggio, Carmen Valente, Giovanna Grimaldi, Luca Palazzo · 2019 · Biochemical Pharmacology
  32. PARP and other prospective targets for poisoning cancer cell metabolism
    Judith Michels, Florine Obrist, Maria Castedo, Ilio Vitale, Guido Kroemer · 2014 · Biochemical Pharmacology
  33. Mitigative effects of the bioactive flavonol fisetin on high‐fat/high‐sucrose induced nonalcoholic fatty liver disease in rats
    Hanaa Hibishy Gaballah, Hemat El‐Sayed El‐Horany, Duaa Samir Helal · 2019 · Journal of Cellular Biochemistry
  34. Alteration of poly(ADP-ribose) metabolism affects murine sperm nuclear architecture by impairing pericentric heterochromatin condensation
    Mirella L. Meyer‐Ficca, Julia D. Lonchar, Motomasa Ihara, Jessica J. Bader, Ralph G. Meyer · 2013 · Chromosoma
  35. Hypothalamic NAD+-Sirtuin Axis: Function and Regulation
    Eun Roh, Min‐Seon Kim · 2020 · Biomolecules
  36. Combination Treatment Strategies to Overcome PARP Inhibitor Resistance
    Young Hwa Soung, Jun Chung · 2023 · Biomolecules
  37. Implications of genotypic differences in the generation of a urinary metabolomics radiation signature
    Evagelia C. Laiakis, Evan L. Pannkuk, Maria Elena Diaz-Rubio, Yiwen Wang, Tytus D. Mak, Cynthia Marie Simbulan-Rosenthal, David J. Brenner, Albert J. Fornace · 2016 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
  38. NAD+ Metabolism and Interventions in Premature Renal Aging and Chronic Kidney Disease
    Lucie Chanvillard, Alessandra Tammaro, Vincenzo Sorrentino · 2022 · Cells
  39. Oxidative–Inflammatory Crosstalk and Multi-Target Natural Agents: Decoding Diabetic Vascular Complications
    Jingwen Liu, Kexin Li, Zixin Yi, Saqirile, Changshan Wang, Rui Yang · 2025 · Current Issues in Molecular Biology
  40. Emerging roles of TFE3 in metabolic regulation
    Xingyu Li, Yongming Chen, Siqiao Gong, Hui-Xia Chen, Xiaoyu Li, Xiaoyu Li, Junfeng Hao · 2023 · Cell Death Discovery
  41. The Poly (ADP-Ribose) Polymerase Inhibitor Veliparib and Radiation Cause Significant Cell Line Dependent Metabolic Changes in Breast Cancer Cells
    Vijesh J. Bhute, Yan Ma, Xiaoping Bao, Sean P. Palecek · 2016 · Scientific Reports
  42. Sub-lethal Doses of Polybrominated Diphenyl Ethers, in Vitro, Promote Oxidative Stress and Modulate Molecular Markers Related to Cell Cycle, Antioxidant Balance and Cellular Energy Management
    Simona Manuguerra, Cristóbal Espinosa‐Ruíz, Andrea Santulli, Concetta María Messina · 2019 · International Journal of Environmental Research and Public Health
  43. Parthanatos as a Cell Death Pathway Underlying Retinal Disease
    Scott H. Greenwald, Eric A. Pierce · 2019 · Advances in experimental medicine and biology
  44. NAD+ metabolism and therapeutic strategies in cardiovascular diseases
    Chongxu Shi, Zhaozhi Wen, Yihang Yang, Linsheng Shi, Dong Liu · 2024 · Atherosclerosis Plus
  45. Trial watch – inhibiting PARP enzymes for anticancer therapy
    Antonella Sistigu, Gwenola Manic, Florine Obrist, Ilio Vitale · 2015 · Molecular & Cellular Oncology
  46. Olaparib induces browning of in vitro cultures of human primary white adipocytes
    Lilla Nagy, Boglárka Rauch, Noémi Balla, Gyula Ujlaki, Gréta Nikoletta Kis, Omar Abdul-Rahman, Endre Kristóf, Adrienn Sipos, Miklós Antal, Attila Tóth et al. · 2019 · Biochemical Pharmacology
  47. Involvement of PARPs in cell death
    Francesca Aredia · 2014 · Frontiers in Bioscience-Elite
  48. Synthesis and biological evaluation of a tumor-selective degrader of PARP1
    Chunlan Pu, Shirui Wang, Dan Luo, Yuanyuan Liu, Xinyu Ma, Hongjia Zhang, Su Yu, Suke Lan, Qing Huang, Rui Deng et al. · 2022 · Bioorganic & Medicinal Chemistry
  49. The role of p38 signaling and poly(ADP-ribosyl)ation-induced metabolic collapse in the osteogenic differentiation-coupled cell death pathway
    Agnieszka Robaszkiewicz, Zsuzsanna Valkó, Katalin Éva Kovács, Csaba Hegedűs, Edina Bakondi, Péter Bai, László Virág · 2014 · Free Radical Biology and Medicine
  50. In silicoinvestigation of PARP-1 catalytic domains inholoandapostates for the design of high-affinity PARP-1 inhibitors
    Ramin Ekhteiari Salmas, Ayhan Ünlü, Mine Yurtsever, Sergei Yu. Noskov, Serdar Durdağı · 2015 · Journal of Enzyme Inhibition and Medicinal Chemistry
  51. Kinase-independent role of nuclear RIPK1 in regulating parthanatos through physical interaction with PARP1 upon oxidative stress
    Ki-Hong Jang, Taeik Jang, Eunji Son, Soonjin Choi, Eunhee Kim · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  52. The MacroH2A1.1 – PARP1 Axis at the Intersection Between Stress Response and Metabolism
    Sarah Hurtado-Bagès, Iva Guberović, Marcus Buschbeck · 2018 · Frontiers in Genetics
  53. Isoflavone Aglycones Attenuate Cigarette Smoke-Induced Emphysema via Suppression of Neutrophilic Inflammation in a COPD Murine Model
    Kazuya Kojima, Kazuhisa Asai, Hiroaki Kubo, Arata Sugitani, Yohkoh Kyomoto, Atsuko Okamoto, Kazuhiro Yamada, Naoki Ijiri, Tetsuya Watanabe, Kazuto Hirata et al. · 2019 · Nutrients
  54. Exogenous supplemental NAD+ protect myocardium against myocardial ischemic/reperfusion injury in swine model.
    Xinrong Zhai, Wenzheng Han, Ming Wang, Shaofeng Guan, Xinkai Qu · 2019 · PubMed Central
  55. Poly(ADP) ribose polymerase-1 ablation alters eicosanoid and docosanoid signaling and metabolism in a murine model of contact hypersensitivity
    Borbála Kiss, Magdolna Szántó, Mónika Szklenár, Attila Brunyánszki, Tamás Marosvölgyi, ESZTER SÁROSI, Éva Remenyik, Pál Gergely, László Virág, Támas Décsi et al. · 2014 · Molecular Medicine Reports
  56. Metabolic responses induced by DNA damage and poly (ADP-ribose) polymerase (PARP) inhibition in MCF-7 cells
    Vijesh J. Bhute, Sean P. Palecek · 2015 · Metabolomics
  57. Mutant Nmnat1 leads to a retina-specific decrease of NAD+ accompanied by increased poly(ADP-ribose) in a mouse model of NMNAT1-associated retinal degeneration
    Scott H. Greenwald, Emily E. Brown, Michael J. Scandura, Erin Hennessey, Raymond Farmer, Jianhai Du, Yekai Wang, Eric A. Pierce · 2021 · Human Molecular Genetics
  58. Identification of Protein Substrates of Specific PARP Enzymes Using Analog-Sensitive PARP Mutants and a “Clickable” NAD+ Analog
    Bryan A. Gibson, W. Lee Kraus · 2017 · Methods in molecular biology
  59. Polymorphisms in poly (ADP-ribose) polymerase-1 (PARP1) promoter and 3' untranslated region and their association with PARP1 expression in breast cancer patients.
    Lili Zhai, Shuai Li, Huilan Li, Yi Zheng, Ronggang Lang, Yu Fan, Feng Gu, Xiaojing Guo, Xinmin Zhang, Li Fu · 2015 · Europe PMC (PubMed Central)
  60. SIRT1 activation and its effect on intercalated disc proteins as a way to reduce doxorubicin cardiotoxicity
    Ekaterina Podyacheva, Yana G. Toropova · 2022 · Frontiers in Pharmacology
  61. Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma
    Lorenza P. Ferretti, Flurina Böhi, Deena M. Leslie Pedrioli, Phil Fang Cheng, Elena Ferrari, Petra Baumgaertner, Abdiel Alvarado-Diaz, Federica Sella, Alessandra Cereghetti, Patrick Turko et al. · 2023 · Cancer Research
  62. Programmed cell death with a necrotic-like phenotype
    Michael J. Morgan, Zheng-gang Liu · 2013 · BioMolecular Concepts
  63. The Effect ofPoly(ADP-ribose) Polymerase-1Gene 3′Untranslated Region Polymorphism in Colorectal Cancer Risk among Saudi Cohort
    Abdullah M. Alhadheq, Jilani Purusottapatnam Shaik, Abdullah M. Alamri, Abdulrahman Aljebreen, Othman Alharbi, Majid Abdularahman Almadi, Faten Alhadeq, Nahla Ali Azzam, Abdelhabib Semlali, Mohammad A. Alanazi et al. · 2016 · Disease Markers
  64. Poly(ADP-ribose) polymerase-2 is essential for endometrial receptivity and blastocyst implantation, and regulated by caspase-8
    Upendra Kumar Soni, Sangappa Basanna Chadchan, Anubha Joshi, Vijay Kumar, Vineet Kumar Maurya, Raj Kumar Verma, Rajesh Kumar Jha · 2020 · Molecular and Cellular Endocrinology
  65. Poly(ADP-ribose) polymerase-2 is a lipid-modulated modulator of muscular lipid homeostasis
    Judit Márton, Mária Péter, Gabor E. Balogh, Beáta Bódi, András Vida, Magdolna Szántó, Dóra Bojcsuk, Laura Jankó, Harjit Pal Bhattoa, Imre Gombos et al. · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  66. Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy
    Jean‐Rémy Marchand, Andrea Carotti, Daniela Passeri, Paolo Filipponi, Paride Liscio, Emidio Camaioni, Roberto Pellicciari, Antimo Gioiello, Antonio Macchiarulo · 2014 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  67. Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Attenuated Hepatic Triglyceride Accumulation in Alcoholic Fatty Liver Disease in Mice
    Shishun Huang, Bing Zhang, Yingli Chen, Huan Liu, Yang Liu, Xin Li, Zhiwei Bao, Zhenyuan Song, Zhigang Wang · 2018 · Journal of Pharmacology and Experimental Therapeutics
  68. Silencing of PARP2 Blocks Autophagic Degradation
    Laura Jankó, Zsanett Sári, Tündé Kovàcs, Gréta Nikoletta Kis, Magdolna Szántó, Miklós Antal, Gábor Juhász, Péter Bai · 2020 · Cells
  69. Neuralized-like protein 4 (NEURL4) mediates ADP-ribosylation of mitochondrial proteins
    Maria Dafne Cardamone, Yuan Gao, Julian Kwan, Vanessa Hayashi, Megan Sheeran, Junxiang Xu, Justin English, Joseph Orofino, Andrew Emili, Valentina Perissi · 2021 · The Journal of Cell Biology
  70. Aldehyde dehydrogenase 2 and PARP1 interaction modulates hepatic HDL biogenesis by LXRα-mediated ABCA1 expression
    Luxiao Li, Shanshan Zhong, Rui Li, Ningning Liang, Lili Zhang, Xia Shen, Xiaodong Xu, Xin Chen, Shiting Chen, Yongzhen Tao et al. · 2022 · JCI Insight
  71. Exposure to fluoride exacerbates the cognitive deficit of diabetic patients living in areas with endemic fluorosis, as well as of rats with type 2 diabetes induced by streptozotocin via a mechanism that may involve excessive activation of the poly(ADP ribose) polymerase-1/P53 pathway
    Jie Xiang, Xiaolan Qi, Kun Cao, Long‐Yan Ran, Xiaoxiao Zeng, Xiao Xiao, Wei Liao, Wen-Wen He, Wei Hong, Yan He et al. · 2023 · The Science of The Total Environment
  72. Exploring the effect of PARP-1 flexibility in docking studies
    Albert A. Antolín, Andrea Carotti, Roberto Nuti, Aydie Hakkaya, Emidio Camaioni, Jordi Mestres, Roberto Pellicciari, Antonio Macchiarulo · 2013 · Journal of Molecular Graphics and Modelling
  73. Poly(ADP-ribosylated) proteins in mononuclear cells from patients with type 2 diabetes identified by proteomic studies
    Alessandra Giorgi, Italo Tempera, Giorgia Napoletani, Diego Drovandi, Cinzia Potestà, Sara Martire, Elisabetta Mandosi, Tiziana Filardi, Maria Eugenia Schininà, Susanna Morano et al. · 2017 · Acta Diabetologica
  74. Discovery of a First-in-Class CD38 Inhibitor for the Treatment of Mitochondrial Myopathy
    Yue Li, Yuanyuan Liu, Yong Zhang, Yong Wu, Zili Xing, JianFei Wang, Guo-Huang Fan · 2023 · Journal of Medicinal Chemistry
  75. Inhibitors of telomerase and poly(ADP-ribose) polymerases synergize to limit the lifespan of pancreatic cancer cells
    Katrina M. Burchett, Asserewou Etekpo, Surinder K. Batra, Ying Yan, Michel M. Ouellette · 2017 · Oncotarget
  76. Phospholipid Biosynthesis: An Unforeseen Modulator of Nuclear Metabolism
    Hong Qiu, Cunqi Ye · 2025 · Biology of the Cell
  77. The cross-talk between PARylation and SUMOylation in C/EBPβ at K134 site participates in pathological cardiac hypertrophy
    Luping Wang, Panxia Wang, Suowen Xu, Zhuoming Li, Dayue Darrel Duan, Jiantao Ye, Jingyan Li, Yan-qing Ding, Wenqing Zhang, Jing Lü et al. · 2021 · International Journal of Biological Sciences
  78. Functional deterioration of vascular mitochondrial and glycolytic capacity in the aortic rings of aged mice
    Agnieszka Karaś, Anna Bar, Kanchana Pandian, Agnieszka Jasztal, Zuzanna Kuryłowicz, Barbara Anna Kutryb-Zając, Elżbieta Buczek, Stefano Rocchetti, Tasnim Mohaissen, Agata Jędrzejewska et al. · 2024 · GeroScience
  79. NAD(P)H-quinone oxidoreductase 1 induces complicated effects on mitochondrial dysfunction and ferroptosis in an expression level-dependent manner
    Jaewang Lee, Dong‐Hoon Hyun · 2024 · BioScience Trends
  80. Practical approaches to the nutritional management of nonalcoholic fatty liver disease
    Leila Freidoony, In Deok Kong · 2014 · Integrative Medicine Research
  81. Chemo-enzymatic synthesis of isotopically labeled nicotinamide riboside
    Ai Tran, Ryota Yokose, Yana Cen · 2018 · Organic & Biomolecular Chemistry
  82. Acyl-CoA-binding domain containing 3 modulates NAD+ metabolism through activating poly(ADP-ribose) polymerase 1
    Yong Chen, Sookhee Bang, Soo-Hyun Park, Hanyuan Shi, Sangwon F. Kim · 2015 · Biochemical Journal
  83. PARP2 poly(ADP-ribosyl)ates nuclear factor erythroid 2-related factor 2 (NRF2) affecting NRF2 subcellular localization
    Laura Jankó, Emese Tóth, Miklós Laczik, Boglárka Rauch, Eszter Anna Janka, Bálint L. Bálint, Péter Bai · 2023 · Scientific Reports
  84. A Molecular Perspective and Role of NAD+ in Ovarian Aging
    Mehboob Ahmed, Umair Riaz, Haimiao Lv, Liguo Yang · 2024 · International Journal of Molecular Sciences
  85. A new facet of ADP-ribosylation reactions SIRTs and PARPs interplay
    Maria Rosaria Faraone Mennella · 2015 · Frontiers in bioscience
  86. Sequence variants in the bovine silent information regulator 6, their linkage and their associations with body measurements and carcass quality traits in Qinchuan cattle
    Linsheng Gui, Bijie Jiang, Yaran Zhang, Linsen Zan · 2015 · Gene
  87. Automodification of PARP and Fatty Acid-Based Membrane Lipidome as a Promising Integrated Biomarker Panel in Molecular Medicine
    Anna Rita Bianchi, Carla Ferreri, Simona Ruggiero, Simone Deplano, Valentina Sunda, Giuseppe Galloro, Cesare Formisano, Maria Rosaria Faraone Mennella · 2016 · Biomarkers in Medicine
  88. Nicotinamide Riboside for the Prevention and Treatment of Doxorubicin Cardiomyopathy. Opportunities and Prospects
    Ekaterina Podyacheva, Yana G. Toropova · 2021 · Nutrients
  89. Peroxisome proliferator-activated receptor γ coactivator 1α maintains NAD+ bioavailability protecting against steatohepatitis
    Weiyan Shen, Xingyong Wan, Jiahui Hou, Zhu Liu, Genxiang Mao, Xiaogang Xu, Chaohui Yu, Xudong Zhu, Zhenyu Ju · 2022 · Life Medicine
  90. Targeting DNA damage response in pancreatic ductal adenocarcinoma: A review of preclinical and clinical evidence
    Fatemeh Moosavi, Bahareh Hassani, Somayeh Nazari, Luciano Saso, Omidreza Firuzi · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  91. Hesperidin promotes lysosomal biogenesis in chronically ethanol‐induced cardiotoxicity in rats: A proposed mechanisms of protection
    Hanaa Hibishy Gaballah, Heba Bassiony Ghanem, Nahid Tahoon, Darin A. Mohamed, Abla M. Ebeid · 2018 · Journal of Biochemical and Molecular Toxicology
  92. Depletion of PARP10 inhibits the growth and metastatic potential of oral squamous cell carcinoma
    Zihui Zhou, Bing Wei, Yu Liu, Tian Liu, Sien Zeng, Jinfeng Gan, Guangying Qi · 2022 · Frontiers in Genetics
  93. Poly(ADP-ribose) in the bone: From oxidative stress signal to structural element
    Csaba Hegedűs, Agnieszka Robaszkiewicz, Petra Lakatos, Éva Szabó, László Virág · 2015 · Free Radical Biology and Medicine
  94. Protective Effects of GalNac-Modified Red Blood Cell-Derived Extracellular Vesicles Against Liver Diseases
    Xiaofang Huang, Jie Yang, Yuanyuan Hu, Shuai Li, Zhijian Cai, Chen Li, Weidong Qin, Gensheng Zhang · 2025 · International Journal of Nanomedicine
  95. Unravelling the genetics and epigenetics of the ageing tumour microenvironment in cancer
    Hariharan Easwaran, Ashani T. Weeraratna · 2025 · Nature reviews. Cancer
  96. PAR level mediates the link between ROS and inflammatory response in patients with type 2 diabetes mellitus
    Michele Zampieri, Katsiaryna Karpach, Gerardo Salerno, Anna Raguzzini, Ilaria Barchetta, Flavia Agata Cimini, Sara Dule, Giovanna DE MATTEIS, Giuseppe Zardo, Marina Borro et al. · 2024 · Redox Biology
  97. Chitosan/siRNA nanoparticles targeting PARP-1 attenuate Neuroinflammation and apoptosis in hyperglycemia-induced oxidative stress in Neuro2a cells
    Moqbel Ali Moqbel Redhwan, Hariprasad M.G., Suman Samaddar, Duaa Abdullah Bafail, Sumaia Abdulbari Ahmed Ali Hard, Sourav Guha · 2024 · International Journal of Biological Macromolecules
  98. Nicotinamide Adenine Dinucleotide (NAD + )-Dependent Signaling in Neurological Disorders
    Mariana Bresque, Daniel Esteve, Mariana Pehar, Marcelo R. Vargas · 2023 · Antioxidants and Redox Signaling
  99. Genetic determinants of adiponectin regulation revealed by pregnancy
    Marie‐France Hivert, Denise M. Scholtens, Catherine Allard, Michael Nodzenski, Luigi Bouchard, Diane Brisson, Lynn P. Lowe, Ian C. McDowell, Tim Reddy, Zari Dastani et al. · 2017 · Obesity
  100. Intrazelluläre Visualisierung der Entstehung von Poly(ADP‐Ribose) mit bioorthogonal funktionalisierten NAD+‐Analoga
    Sarah Wallrodt, Annette Buntz, Yan Wang, Andreas Zumbusch, Andreas Marx · 2016 · Angewandte Chemie